ARCHIVES

Drug pricing: Amgen’s “bundling” violates antitrust laws, J&J claims in suit.

This article is from The Cancer Letter archive.

Vol. 31 No. 37 | October 14, 2005

Download PDF Visit The Full Archive

Related Articles

Conference Explores Hype And Hope In Communicating Science News

May 15, 1998

Children of Male Cancer Survivors Have Highrt Risk of Birth Defects

February 25, 2011

NCI Details How Year 2000 Goals Can Be Reached Bypass Budget Spells Out How Much It Will Cost

June 8, 1984

AGS-003 Increased Survival In Combination with Sunitinib

February 24, 2012

Conversation with The Cancer Letter: Statistician Lori Dodd Saw Research Question In the Midst of 2007 ODAC Debate Over Avastin

July 27, 2012

NCI, Komen Foundation Fund Summit meeting On Breast Cancer

October 8, 1993